Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 50   

Articles published

SKBI 4.22 -0.19 (-4.31%)
price chart
Update: Skystar Bio-Pharmaceutical Company Q3 Earnings - Key Developments ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) reported double-digit increases for both revenue and net income for Q3. Revenue increased 14.8% to $18.4 million, while net income increased 32% to $4.9 million or $0.57 per fully diluted share.
Related articles »  
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Skystar Bio-Pharmaceutical Company: Skystar Bio-Pharmaceutical Reports ...  The Wall Street Transcript
Related articles »  
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
NEW YORK ( TheStreet) -- Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI) has been upgraded by TheStreet Ratings from sell to hold.
Related articles »  
Skystar Bio - Pharmaceutical Company (SKBI) Q2 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Second Quarter Fiscal 2014 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Skystar Bio-Pharmaceutical to File Financial Results for Second Quarter of ...  Marketwired (press release)
Related articles »  
Skystar Bio-Pharmaceutical to File Financial Results for Third Quarter of ...
XI'AN, CHINA, Nov 14, 2014 (Marketwired via COMTEX) -- Skystar Bio-Pharmaceutical Company SKBI, +1.55% ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, ...
Skystar Bio-Pharmaceutical Reports Third Quarter Fiscal Year 2014 Financial ...  Marketwired (press release)
Skystar Bio-Pharmaceutical Company: Skystar Bio-Pharmaceutical to File ...  The Wall Street Transcript
Related articles »  
Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results ...
Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results - Earnings Call Transcript. May. 16, 2014 10:12 AM ET | About: Skystar Bio - Pharmaceutical Company (SKBI) by: SA Transcripts. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI).
Skystar Bio-Pharmaceutical to File Financial Results for First Quarter of ...  Marketwired (press release)
Related articles »  
Skystar Bio-Pharmaceutical Announces $5 Million Registered Direct Offering
XI'AN, CHINA--(Marketwired - Jul 16, 2014) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, today announces that it has entered into ...
Related articles »  
Mid-Day Watchlist: Skystar Bio Pharmaceutical Company (SKBI), Concert ...
Skystar Bio Pharmaceutical Company (SKBI) of the Healthcare sector has gained 3.37%, a change from open of 1.45% ($0.17 per share) at mid-day Monday with a volume of 041,412 shares.
Related articles »  
Weekly Top Performers: Meru Networks, Inc. (MERU), Skystar Bio ...
Skystar Bio Pharmaceutical Company (SKBI) of the Healthcare sector finished up the week performaing at 10.45% with a volume of 035,286 shares, performing above average.
Closing Bell Reports: Skystar Bio Pharmaceutical Company (SKBI), Synutra ...
Skystar Bio Pharmaceutical Company (SKBI) of the Healthcare sector gained 1.43%, a change from open of 1.4300% ($0.06 per share) at the close of the normal trading day Tuesday Nov 4th, 2014 with a volume of 9115 shares. Skystar Bio Pharmaceutical ...